Cannabis marketing study: do labels trick users into riskier choices?
NCT ID NCT07513337
First seen Jun 25, 2026 · Last updated Sep 18, 2026 · Updated 7 times
Summary
This study looks at how the labels and marketing claims on cannabis products affect what people think about the product's risks and effects. About 2,000 adults in states where recreational cannabis is legal will answer online survey questions after viewing a cannabis advertisement. The goal is to understand how marketing influences perceptions, expectancies, and willingness to use cannabis.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help regulators understand how cannabis marketing affects user perceptions and intentions, potentially informing future labeling policies.
- What could go wrong
- This is an online survey study, not a clinical trial testing a treatment. Results are based on self-reported perceptions and may not reflect real-world behavior.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
3,035 people
The number who actually took part.
- Started
-
Apr 2026
- Finished
-
Jul 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age = 21+ * Live in in a US state (or Washington D.C.) in which recreational cannabis sale is legal and implemented * For inexperienced users: lifetime cannabis use \>1 \& \<= 10 * For experienced users: lifetime cannabis use\>10 \& \<100, past month cannabis use\>0 Exclusion Criteria: * Under age 21 * Does not live in a US state (or Washington D.C.) in which recreational cannabis sale is legal and implemented * Lifetime cannabis use \>=100 times * Lifetime cannabis use \<1 time * Lifetime cannabis use\>10 \& \<100 AND past month cannabis use=0
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cannabis use are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
2213 McElderry St.
Baltimore, Maryland, 21205, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can rewards and remote coaching help people cut back on cannabis?
- Can a short tobacco break curb cannabis cravings?
- Texting teens to tame risky drinking and weed use?
- Can a blood pressure medication curb cannabis cravings?
- Could cannabis help fight diabetes? a study investigates
- A 5-session toolkit aims to curb teen cannabis use — will it work?